Paul Benson

2.9k citations

53 papers · 1.3k indexed · h-index 20

Impact in

Virology top 2%
- HIV Research and Treatment
Dermatology top 2%

Papers in

Virology 14
- HIV Research and Treatment 14
Dermatology 14
- Cancer and Skin Lesions 5

Co-authors: Gordon Crofoot A. Wallace Hayes Harry E. Heath Andrew Cheng Purnima Sau Renata J.M. Engler Edward N. Squire Naomi Aronson
Journals: Journal of the American Academy of Dermatology (12 papers)Open Forum Infectious Diseases (5 papers)Clinical Infectious Diseases (3 papers)AIDS (3 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (2 papers)
Partner nations: United States United Kingdom Thailand

In The Last Decade

Paul Benson

50 papers receiving 1.3k citations

Peers

Countries citing papers authored by Paul Benson

Since Specialization

Citations

This map shows the geographic impact of Paul Benson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Benson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Benson more than expected).

Fields of papers citing papers by Paul Benson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Benson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Benson. The network helps show where Paul Benson may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Paul Benson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Paul Benson Line = papers co-authored together Paul Benson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Final efficacy and safety of twice-yearly subcutaneous lenacapavir in treatment-naive people with HIV AIDS ·Debbie Hagins, Mezgebe Berhe, Gordon Crofoot, Moti Ramgopal, James J. Sims, Cheryl McDonald, Peter Ruane, William E. Sanchez, Anita Scribner, Paul Benson, Shanyu Liu, Laurie A. VanderVeen, Hadas Dvory‐Sobol, Martin S. Rhee, Samir K. Gupta	2025	0
2	Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study Medicine ·Indira Brar, Peter Ruane, Mezgebe Berhe, Cynthia Brinson, Paul Benson, Keith Henry, Hui Liu, Kristen Andreatta, Jason T. Hindman, Moti Ramgopal	2025	0
3	Outcomes in people with HIV who resume or switch to bictegravir/emtricitabine/tenofovir alafenamide following a treatment interruption AIDS ·Graeme Moyle, Andre Reynaldi Ishak, Rebeca Sabóia Martins, Anatolii Artemchuk, Dalia S. Morga, Andrea Marongiu, Paul E. Sax, Travis Lim, Wen Xuewen, Paul Benson, Мирзагалямова Зульфия Нурулловна, Richard Elion	2025	1
4	Real-World Effectiveness of Dolutegravir/Lamivudine in People With HIV-1 in Test-and-Treat Settings or With High Baseline Viral Loads: TANDEM Study Subgroup Analyses Infectious Diseases and Therapy ·Paul Benson, J. Casabona i Barbarà, Cynthia Donovan, 李垣, Pierre Fortin, Yolanda Reyes Villamizar, 李阳明, Hannah Wallis, Andrew P. Brogan, L. M. Villasenor-Cendejas, Alan Oglesby	2024	1
5	Cutaneous Exposure to Arsenicals Is Associated with Development of Constrictive Bronchiolitis in Mice American Journal of Respiratory Cell and Molecular Biology ·Ranu Surolia, Joseph Albert Rene Racine, K.G. Dsouza, Saravan kumar, Pooja Singh, А И Бобрускин, Yuanyuan Guo, Zheng Wang, Mahendra Kashyap, Ritesh K. Srivastava, Fengting Ji, Paul Benson, Lamia Akbar, Harrison Kim, Young-il Kim, Aftab Ahmad, Mohammad Athar, Veena B. Antony	2023	2
6	Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial The Lancet HIV ·Samir K. Gupta, Mezgebe Berhe, Gordon Crofoot, Paul Benson, Moti Ramgopal, James J. Sims, Cheryl McDonald, Peter Ruane, Nouf Alturki, Anita Scribner, Shanyu Liu, Laurie A. VanderVeen, Hadas Dvory‐Sobol, Martin S. Rhee, Jared M. Baeten, Ellen Koenig	2022	65
7	PB4 Patient Perspectives on Implementation of a Long-Acting Injectable Antiretroviral Therapy Regimen in HIV US Healthcare Settings: Final Month 12 Results from the CUSTOMIZE Study Value in Health ·Jason Flamm, Cindy Garris, Ronald D’Amico, Hyeon-Chun Jo, Colleen A. McHorney, Lorenzo Bruni, Paul Benson, Blair Thedinger, Britta Büttel, Adelina Sembiring, Geovanny Satama-Bermeo, Gongyu Wen	2021	2
8	1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine Open Forum Infectious Diseases ·Indira Brar, Peter Ruane, Douglas Ward, Jean‐Michel Molina, Anthony Mills, Mezgebe Berhe, Cynthia Brinson, Chenghua Hiu, Paul Benson, Keith Henry, Hailin Huang, Kristen Andreatta, Hal Martin	2020	3
9	Coformulated bictegravir, emtricitabine, tenofovir alafenamide after initial treatment with bictegravir or dolutegravir and emtricitabine/tenofovir alafenamide AIDS ·Paul E. Sax, Edwin DeJesus, Gordon Crofoot, Douglas Ward, Paul Benson, Robin Dretler, Anthony Mills, Cynthia Brinson, Xuelian Wei, Sean E Collins, Andrew Cheng	2018	7
10	Switching to Tenofovir Alafenamide, Coformulated With Elvitegravir, Cobicistat, and Emtricitabine, in HIV-Infected Patients With Renal Impairment JAIDS Journal of Acquired Immune Deficiency Syndromes ·Anton Pozniak, José Ramón Arribas, Joseph Gathe, Samir K. Gupta, Frank A. Post, Ilona Balcerczyk, Anchalee Avihingsanon, Gordon Crofoot, Paul Benson, Kenneth Lichtenstein, Moti Ramgopal, Ploenchan Chetchotisakd, Joseph M. Custodio, Michael E. Abram, Xuelian Wei, Andrew Cheng, Scott McCallister, Devi SenGupta, Marshall W. Fordyce	2015	158
11	The prevalence of transmitted antiretroviral drug resistance in treatment‐naïve patients and factors influencing first‐line treatment regimen selection HIV Medicine ·S M Sallenave, Min Zhang, S. Kusalerdchariya, Barnaby Edward Young, P. F. Oliveira, Paul Benson, C Cohen, Anita Scribner, Hua Hu	2008	17
12	THE UNITED STATES MILITARY AND LEISHMANIASIS Dermatologic Clinics ·Julie Kenner, Naomi Aronson, Paul Benson	1999	11
13	Safety and Efficacy of Intravenous Sodium Stibogluconate in the Treatment of Leishmaniasis: Recent U.S. Military Experience Clinical Infectious Diseases ·Naomi Aronson, Glenn Wortmann, Steven C. Johnson, Joan E. Jackson, Robert A. Gasser, Alan J. Magill, Timothy P. Endy, Philip E. Coyne, Max Grögl, Paul Benson, Jeffrey S. Beard, B.M. Medić, Jeffrey M. Gambel, Richard D. Kreutzer, Charles N. Oster	1998	89
14	Acinic Cell Carcinoma Presenting as an Upper Lip Mass Dermatologic Surgery ·Julie Kenner, Paul Benson, Christopher K. Sinha, J. Healy, Allan C. Harrington, Purnima Sau	1998	4
15	Cutaneous angiosarcoma arising in the radiation site of a congenital hemangioma Journal of the American Academy of Dermatology ·J. Bruce Caldwell, Michael T. Ryan, Paul Benson, William D. James	1995	41
16	PRIMARY CUTANEOUS NOCARDIA INFECTION DUE TO NOCARDIA ASTEROIDES International Journal of Dermatology ·Alaa Bakur Ali Alshaikh, E. Zhurkin, Purnima Sau, Paul Benson	1993	4
17	Epithelioid hemangioendothelioma associated with reflex sympathetic dystrophy Journal of the American Academy of Dermatology ·Lia Ayu Wigati, Purnima Sau, Paul Benson	1992	21
18	Basal cell carcinoma of the nipple Journal of the American Academy of Dermatology ·Yihan, Purnima Sau, Paul Benson	1990	19
19	Buerger's Disease International Journal of Dermatology ·Valter R. de Moraes, William D. James, Paul Benson	1989	4
20	Buerger's Disease International Journal of Dermatology ·Valter R. de Moraes, William D. James, Paul Benson	1989	4

About Paul Benson

Paul Benson is a scholar working on Virology, Dermatology, Microbiology, Infectious Diseases and Emergency Medicine, having authored 53 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (20 papers), HIV Research and Treatment (14 papers), HIV/AIDS Research and Interventions (10 papers), Autoimmune Bullous Skin Diseases (6 papers), HIV-related health complications and treatments (6 papers), Cancer and Skin Lesions (5 papers), Drug-Induced Adverse Reactions (4 papers) and Urticaria and Related Conditions (4 papers). The work is most often cited by research in Virology (273 citations), Dermatology (229 citations), Microbiology (19 citations), Infectious Diseases (436 citations) and Emergency Medicine (158 citations). Paul Benson has collaborated with scholars based in United States, United Kingdom and Thailand. Frequent co-authors include Gordon Crofoot, A. Wallace Hayes, Harry E. Heath, Andrew Cheng, Purnima Sau, Renata J.M. Engler, Edward N. Squire, Naomi Aronson, William D. James and Xuelian Wei. Their work appears in journals such as Journal of the American Academy of Dermatology, Open Forum Infectious Diseases, Clinical Infectious Diseases, AIDS and JAIDS Journal of Acquired Immune Deficiency Syndromes.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact